NICE, France, July 11, 2016 -- OPTrust is investing in an equity portfolio that is benchmarked to the Scientific Beta Developed Multi-Beta Multi-Strategy Relative Volatility (90%) Solution.
One of the characteristics of traditional defensive strategies such as Minimum or Low Volatility is that they are concentrated in low volatility or low beta stocks. Therefore, while over a very long period these defensive strategies outperform cap-weighted indices, over the short term, in a bull market, they could seriously underperform.
It is in this context that researchers from EDHEC-Risk Institute and ERI Scientific Beta have developed a new approach in terms of multi-factor dynamic defensive strategies. The Scientific Beta Multi-Beta Multi-Strategy relative volatility solution indices are no longer exposed to low volatility factors alone but obtain a significant reduction in portfolio volatility through factor diversification. Moreover, these new strategies have a variable defensive bias, which corresponds to dynamic allocation between smart factor indices based on market volatility. It involves ramping up the defensive profile of the strategy when high market volatility makes it necessary. This new approach to defensive smart beta provides not only excess return but also a significant reduction in volatility over the long term compared with cap-weighted benchmarks, while at the same time outperforming in bull markets.
The benefits of dynamic allocation are even more evident in extreme bull markets relative to low volatility strategies, with higher probabilities of outperformance in the short- and medium-terms and a lower maximum relative drawdown.
Noël Amenc, CEO of ERI Scientific Beta, said, "The beauty of ERI Scientific Beta's dynamic defensive solution is that it is defensive when needed. This is reflected in the dynamic nature of the approach. Unlike most defensive approaches on the market, our approach does not focus on a low volatility/low beta factor, but is a diversification approach based on the flagship Scientific Beta Multi-Beta Multi-Strategy indices."
James Davis, CIO of OPTrust, said, "We worked closely with the ERI Scientific Beta team to evaluate different smart beta strategies that aligned with our Member Driven Investing investment objectives. The Multi-Beta, Multi-Strategy solution we chose provides for downside risk mitigation. By employing a dynamic strategy that reduces volatility in times of market stress, we can be more comfortable with our overall equity exposure."
As part of its policy of transferring know-how to the industry, EDHEC-Risk Institute has set up ERI Scientific Beta. ERI Scientific Beta is an original initiative which aims to favour the adoption of the latest advances in smart beta design and implementation by the whole investment industry. Its academic origin provides the foundation for its strategy: offer, in the best economic conditions possible, the smart beta solutions that are most proven scientifically with full transparency of both the methods and the associated risks.
ERI Scientific Beta, 1 George Street, #07-02, Singapore 049145. For further information, please contact: [email protected], Web: www.scientificbeta.com.
Press_release_OPTrust_institutional_mandate http://hugin.info/157174/R/2027627/753586.pdf
HUG#2027627


OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 



